Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
$0.00
$12.81
$13.82
N/AN/A24,050 shsN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
C$0.14
C$0.11
C$0.04
C$0.43
C$20.40M0.2413,602 shs81,445 shs
IBT
IBEX Technologies
C$1.44
C$1.44
C$0.75
C$1.45
C$35.54M-0.0568,888 shs200 shs
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$0.25
-2.0%
C$0.26
C$0.25
C$0.46
C$27.70M0.7265,688 shs25,810 shs
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
C$0.08
+14.3%
C$0.08
C$0.07
C$0.25
C$5.79MN/A93,085 shs212,852 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hemostemix Inc. stock logo
HEM
Hemostemix
0.00%+3.70%+12.00%+33.33%+133.33%
IBT
IBEX Technologies
0.00%0.00%0.00%0.00%0.00%
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00%-2.00%-2.00%-14.04%-38.75%
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/AN/AN/AN/A
IBT
IBEX Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
0.00
N/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
0.00
N/AN/AN/A
IBT
IBEX Technologies
0.00
N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00
N/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AC$0.01 per share10.77C($0.10) per shareN/A
IBT
IBEX Technologies
C$5.77M6.15C$0.92 per share1.56C$0.58 per share2.48
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$39.47M0.70C$0.03 per share8.93C$0.21 per share1.17
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AC$0.03 per share3.18C$0.02 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
-C$5.00M-C$0.03N/AN/AN/A37.07%-349.24%N/A
IBT
IBEX Technologies
C$3.10MC$0.1211.52N/A53.78%21.95%6.42%N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
-C$12.93M-C$0.12N/AN/A-32.75%-38.02%-7.55%N/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A-C$0.02N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
N/AN/AN/AN/AN/A
IBT
IBEX Technologies
N/A3.11%N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/A
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/A
Hemostemix Inc. stock logo
HEM
Hemostemix
-55.07
0.04
0.48
IBT
IBEX Technologies
11.06
6.24
4.93
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
71.72
1.42
1.11
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A
6.14
6.03
CompanyEmployeesShares OutstandingFree FloatOptionable
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/ANot Optionable
Hemostemix Inc. stock logo
HEM
Hemostemix
N/A145.73 millionN/ANot Optionable
IBT
IBEX Technologies
N/A24.68 millionN/ANot Optionable
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
249113.06 millionN/ANot Optionable
Revive Therapeutics Ltd stock logo
RVV
Revive Therapeutics
N/A72.41 millionN/ANot Optionable

Recent News About These Companies

Revive Therapeutics Ltd.
Revive Therapeutics Ltd. (RVV.NE)
Revive Therapeutics Ltd. (RVVTF)
Revive Therapeutics provides update on research study of bucillamine
Revive Therapeutics Ltd. (RVV.CN)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Federated Enhanced Treasury Income Fund stock logo

Federated Enhanced Treasury Income Fund NYSE:FTT

Federated Premier Intermediate Municipal Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income tax, including the federal alternative minimum tax (AMT). The Fund's portfolio of investments include various sectors namely transportation, special tax, hospital, education, public power, senior care, water and sewer, general obligation-local, industrial development bond/pollution control revenue and general obligation-state. The Fund invests in intermediate-term, tax-exempt municipal bonds diversified among states, sectors and issuers. Federated Investment Management Company is the advisor of the Fund.

Hemostemix stock logo

Hemostemix CVE:HEM

C$0.14 0.00 (0.00%)
As of 07/4/2025 10:34 AM Eastern

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

IBEX Technologies CVE:IBT

C$1.44 0.00 (0.00%)
As of 04/5/2024

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Nanalysis Scientific stock logo

Nanalysis Scientific CVE:NSCI

C$0.24 -0.01 (-2.00%)
As of 07/4/2025 03:08 PM Eastern

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

Revive Therapeutics stock logo

Revive Therapeutics CVE:RVV

C$0.08 +0.01 (+14.29%)
As of 07/22/2019

Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.